4l0p
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
+ | |||
==Structure of the human EphA3 receptor ligand binding domain complexed with ephrin-A5== | ==Structure of the human EphA3 receptor ligand binding domain complexed with ephrin-A5== | ||
<StructureSection load='4l0p' size='340' side='right' caption='[[4l0p]], [[Resolution|resolution]] 2.26Å' scene=''> | <StructureSection load='4l0p' size='340' side='right' caption='[[4l0p]], [[Resolution|resolution]] 2.26Å' scene=''> | ||
Line 4: | Line 5: | ||
<table><tr><td colspan='2'>[[4l0p]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4L0P OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4L0P FirstGlance]. <br> | <table><tr><td colspan='2'>[[4l0p]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4L0P OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4L0P FirstGlance]. <br> | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr> | ||
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4l0p FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4l0p OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4l0p RCSB], [http://www.ebi.ac.uk/pdbsum/4l0p PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4l0p FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4l0p OCA], [http://pdbe.org/4l0p PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4l0p RCSB], [http://www.ebi.ac.uk/pdbsum/4l0p PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4l0p ProSAT]</span></td></tr> |
</table> | </table> | ||
== Disease == | == Disease == | ||
Line 18: | Line 19: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
+ | <div class="pdbe-citations 4l0p" style="background-color:#fffaf0;"></div> | ||
==See Also== | ==See Also== |
Revision as of 12:09, 12 April 2017
Structure of the human EphA3 receptor ligand binding domain complexed with ephrin-A5
|